Table 2. Effects of kallistatin on MDA and SOD in CCl₄-induced liver fibrosis rats (n = 8).

Treatment	MDA(nmol/mg)	SOD(nU/mg)
negative control	0.48±0.14	37.13±3.70
CCl4	0.95±0.09##	22.66±2.66##
CCl4+kallistatin (0.125 mg/kg)	0.72±0.10*	27.45±3.48**
CCl4+kallistatin (0.5 mg/kg)	0.59±0.08**	30.56±4.56**
CCl4+kallistatin (2 mg/kg)	0.48±0.07**	33.39±3.32**

The results are showed as the mean±SD (n = 8).

^## p<0.01 vs. negative control;

*p<0.05 vs. model control group;

**p<0.01 vs. model control group.